FDA's Resolution of Ozempic Shortage Sends Hims & Hers Stocks Plummeting

FDA's Resolution of Ozempic Shortage Sends Hims & Hers Stocks Plummeting

By: Darius Kingsley Feb, 22 2025

Hims & Hers Health saw its stock drop by 19% after the FDA announced the resolution of the Ozempic shortage, impacting the company's alternative formulations. With the mandate to stop production of compounded versions, the company is planning to release a generic alternative to stay competitive.

Read More
Target Alters DEI Initiatives Amid Trump's Executive Order Mandates

Target Alters DEI Initiatives Amid Trump's Executive Order Mandates

By: Darius Kingsley Jan, 25 2025

In response to President Trump's executive order, Target is modifying its approach to diversity, equity, and inclusion initiatives. While the company is concluding existing DEI goals and winding down its Racial Equity Action and Change initiatives by 2025, it remains committed to fostering a sense of belonging. The rearrangement includes halting diversity-specific surveys and revamping supplier strategies to emphasize broader inclusion, including a focus on small businesses.

Read More

Popular Articles

Target Alters DEI Initiatives Amid Trump's Executive Order Mandates

Target Alters DEI Initiatives Amid Trump's Executive Order Mandates

 Darius Kingsley

Categories

Archives